Key Features Relevant to Select Antigens and TCR From the MHC-Mismatched Repertoire to Treat Cancer
Adoptive transfer of T cells transgenic for tumor-reactive T-cell receptors (TCR) is an attractive immunotherapeutic approach. However, clinical translation is so far limited due to challenges in the identification of suitable target antigens as well as TCRs that are concurrent safe and efficient. D...
Main Authors: | Stefan Audehm, Manuel Glaser, Matteo Pecoraro, Eva Bräunlein, Sabine Mall, Richard Klar, Manuel Effenberger, Julian Albers, Henrique de Oliveira Bianchi, Janet Peper, Nahid Yusufi, Dirk H. Busch, Stefan Stevanović, Matthias Mann, Iris Antes, Angela M. Krackhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01485/full |
Similar Items
-
The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering
by: D. V. Shevyrev, et al.
Published: (2022-11-01) -
Integrating Experiment and Theory to Understand TCR-pMHC Dynamics
by: Ashley M. Buckle, et al.
Published: (2018-12-01) -
CROSS-REACTIVITY OF TCR REPERTOIRE: CURRENT CONCEPTS, CHALLENGES AND IMPLICATION FOR ALLOTRANSPLANTATION
by: Nicolas eDegauque, et al.
Published: (2016-03-01) -
Performance comparison of TCR-pMHC prediction tools reveals a strong data dependency
by: Lihua Deng, et al.
Published: (2023-04-01) -
TCR Recognition of Peptide–MHC-I: Rule Makers and Breakers
by: Christopher Szeto, et al.
Published: (2020-12-01)